Annual FCF
$629.50 M
-$323.90 M-33.97%
31 December 2023
Summary:
Edwards Lifesciences annual free cash flow is currently $629.50 million, with the most recent change of -$323.90 million (-33.97%) on 31 December 2023. During the last 3 years, it has fallen by -$17.50 million (-2.70%). EW annual FCF is now -55.11% below its all-time high of $1.40 billion, reached on 31 December 2021.EW Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$294.50 M
+$8.40 M+2.94%
30 September 2024
Summary:
Edwards Lifesciences quarterly free cash flow is currently $294.50 million, with the most recent change of +$8.40 million (+2.94%) on 30 September 2024. Over the past year, it has dropped by -$61.70 million (-17.32%). EW quarterly FCF is now -61.35% below its all-time high of $762.00 million, reached on 30 June 2014.EW Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$490.10 M
-$61.70 M-11.18%
30 September 2024
Summary:
Edwards Lifesciences TTM free cash flow is currently $490.10 million, with the most recent change of -$61.70 million (-11.18%) on 30 September 2024. Over the past year, it has dropped by -$284.80 million (-36.75%). EW TTM FCF is now -65.69% below its all-time high of $1.43 billion, reached on 31 March 2022.EW TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.0% | -17.3% | -36.8% |
| 3 y3 years | -2.7% | -37.5% | -65.2% |
| 5 y5 years | -8.1% | -18.5% | -39.4% |
EW Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -55.1% | at low | -37.5% | +312.2% | -65.7% | +95.1% |
| 5 y | 5 years | -55.1% | at low | -37.5% | +312.2% | -65.7% | +95.1% |
| alltime | all time | -55.1% | +899.2% | -61.4% | +312.2% | -65.7% | +9702.0% |
Edwards Lifesciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $294.50 M(+2.9%) | $490.10 M(-11.2%) |
| June 2024 | - | $286.10 M(-306.1%) | $551.80 M(+119.7%) |
| Mar 2024 | - | -$138.80 M(-387.4%) | $251.20 M(-60.1%) |
| Dec 2023 | $629.50 M(-34.0%) | $48.30 M(-86.4%) | $629.50 M(-18.8%) |
| Sept 2023 | - | $356.20 M(-2556.6%) | $774.90 M(+15.9%) |
| June 2023 | - | -$14.50 M(-106.1%) | $668.70 M(-31.2%) |
| Mar 2023 | - | $239.50 M(+23.6%) | $972.30 M(+2.0%) |
| Dec 2022 | $953.40 M(-32.0%) | $193.70 M(-22.5%) | $953.40 M(-8.3%) |
| Sept 2022 | - | $250.00 M(-13.5%) | $1.04 B(-17.5%) |
| June 2022 | - | $289.10 M(+31.1%) | $1.26 B(-11.7%) |
| Mar 2022 | - | $220.60 M(-21.2%) | $1.43 B(+1.9%) |
| Dec 2021 | $1.40 B(+116.7%) | $279.80 M(-40.6%) | $1.40 B(-0.5%) |
| Sept 2021 | - | $471.20 M(+3.2%) | $1.41 B(+34.1%) |
| June 2021 | - | $456.80 M(+134.9%) | $1.05 B(+46.6%) |
| Mar 2021 | - | $194.50 M(-32.1%) | $716.60 M(+10.8%) |
| Dec 2020 | $647.00 M(-28.5%) | $286.30 M(+153.8%) | $647.00 M(-6.5%) |
| Sept 2020 | - | $112.80 M(-8.3%) | $692.10 M(-26.4%) |
| June 2020 | - | $123.00 M(-1.5%) | $940.50 M(-13.5%) |
| Mar 2020 | - | $124.90 M(-62.3%) | $1.09 B(+20.2%) |
| Dec 2019 | $904.50 M(+32.0%) | $331.40 M(-8.3%) | $904.50 M(+11.9%) |
| Sept 2019 | - | $361.20 M(+34.1%) | $808.40 M(+14.8%) |
| June 2019 | - | $269.40 M(-568.5%) | $704.40 M(+34.8%) |
| Mar 2019 | - | -$57.50 M(-124.4%) | $522.40 M(-23.7%) |
| Dec 2018 | $685.00 M(-17.0%) | $235.30 M(-8.5%) | $685.00 M(-9.2%) |
| Sept 2018 | - | $257.20 M(+194.3%) | $754.30 M(-2.3%) |
| June 2018 | - | $87.40 M(-16.8%) | $772.00 M(-5.9%) |
| Mar 2018 | - | $105.10 M(-65.5%) | $820.60 M(-0.6%) |
| Dec 2017 | $825.20 M(+69.4%) | $304.60 M(+10.8%) | $825.20 M(+25.3%) |
| Sept 2017 | - | $274.90 M(+102.1%) | $658.50 M(+21.7%) |
| June 2017 | - | $136.00 M(+24.0%) | $541.20 M(+4.6%) |
| Mar 2017 | - | $109.70 M(-20.4%) | $517.30 M(+6.2%) |
| Dec 2016 | $487.00 M(+9.9%) | $137.90 M(-12.5%) | $487.00 M(+18.3%) |
| Sept 2016 | - | $157.60 M(+40.6%) | $411.60 M(-4.4%) |
| June 2016 | - | $112.10 M(+41.2%) | $430.50 M(-8.4%) |
| Mar 2016 | - | $79.40 M(+27.0%) | $470.10 M(+6.1%) |
| Dec 2015 | $443.20 M(-52.3%) | $62.50 M(-64.6%) | $443.20 M(+3.4%) |
| Sept 2015 | - | $176.50 M(+16.3%) | $428.60 M(+74.1%) |
| June 2015 | - | $151.70 M(+189.0%) | $246.20 M(-71.3%) |
| Mar 2015 | - | $52.50 M(+9.6%) | $856.50 M(-7.8%) |
| Dec 2014 | $928.60 M(+156.1%) | $47.90 M(-911.9%) | $928.60 M(-4.3%) |
| Sept 2014 | - | -$5.90 M(-100.8%) | $970.80 M(-10.6%) |
| June 2014 | - | $762.00 M(+511.6%) | $1.09 B(+156.9%) |
| Mar 2014 | - | $124.60 M(+38.3%) | $422.90 M(+16.6%) |
| Dec 2013 | $362.60 M(+47.3%) | $90.10 M(-17.8%) | $362.60 M(+5.7%) |
| Sept 2013 | - | $109.60 M(+11.2%) | $343.10 M(+1.2%) |
| June 2013 | - | $98.60 M(+53.3%) | $339.10 M(-5.6%) |
| Mar 2013 | - | $64.30 M(-8.9%) | $359.10 M(+45.9%) |
| Dec 2012 | $246.10 M | $70.60 M(-33.1%) | $246.10 M(+3.6%) |
| Sept 2012 | - | $105.60 M(-11.0%) | $237.50 M(+4.3%) |
| June 2012 | - | $118.60 M(-343.5%) | $227.80 M(+30.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$48.70 M(-178.5%) | $174.50 M(-22.1%) |
| Dec 2011 | $223.90 M(+18.8%) | $62.00 M(-35.3%) | $223.90 M(-4.4%) |
| Sept 2011 | - | $95.90 M(+46.9%) | $234.20 M(+7.3%) |
| June 2011 | - | $65.30 M(+9228.6%) | $218.30 M(+17.8%) |
| Mar 2011 | - | $700.00 K(-99.0%) | $185.30 M(-1.6%) |
| Dec 2010 | $188.40 M(+86.0%) | $72.30 M(-9.6%) | $188.40 M(+19.0%) |
| Sept 2010 | - | $80.00 M(+147.7%) | $158.30 M(+15.0%) |
| June 2010 | - | $32.30 M(+750.0%) | $137.70 M(-9.5%) |
| Mar 2010 | - | $3.80 M(-91.0%) | $152.20 M(+50.2%) |
| Dec 2009 | $101.30 M(+34.7%) | $42.20 M(-29.0%) | $101.30 M(+6.7%) |
| Sept 2009 | - | $59.40 M(+26.9%) | $94.90 M(+155.8%) |
| June 2009 | - | $46.80 M(-199.4%) | $37.10 M(+408.2%) |
| Mar 2009 | - | -$47.10 M(-231.6%) | $7.30 M(-90.3%) |
| Dec 2008 | $75.20 M(-49.1%) | $35.80 M(+2137.5%) | $75.20 M(-23.2%) |
| Sept 2008 | - | $1.60 M(-90.6%) | $97.90 M(-30.1%) |
| June 2008 | - | $17.00 M(-18.3%) | $140.00 M(-4.1%) |
| Mar 2008 | - | $20.80 M(-64.4%) | $146.00 M(-1.2%) |
| Dec 2007 | $147.70 M(-13.8%) | $58.50 M(+33.9%) | $147.70 M(+4.2%) |
| Sept 2007 | - | $43.70 M(+90.0%) | $141.80 M(+1.1%) |
| June 2007 | - | $23.00 M(+2.2%) | $140.30 M(-1.9%) |
| Mar 2007 | - | $22.50 M(-57.2%) | $143.00 M(-16.6%) |
| Dec 2006 | $171.40 M(+99.8%) | $52.60 M(+24.6%) | $171.40 M(+23.6%) |
| Sept 2006 | - | $42.20 M(+64.2%) | $138.70 M(+11.2%) |
| June 2006 | - | $25.70 M(-49.5%) | $124.70 M(+2.4%) |
| Mar 2006 | - | $50.90 M(+155.8%) | $121.80 M(+42.0%) |
| Dec 2005 | $85.80 M(-37.9%) | $19.90 M(-29.4%) | $85.80 M(-11.6%) |
| Sept 2005 | - | $28.20 M(+23.7%) | $97.10 M(-20.0%) |
| June 2005 | - | $22.80 M(+53.0%) | $121.30 M(-0.4%) |
| Mar 2005 | - | $14.90 M(-52.2%) | $121.80 M(-11.8%) |
| Dec 2004 | $138.10 M(+32.5%) | $31.20 M(-40.5%) | $138.10 M(-24.7%) |
| Sept 2004 | - | $52.40 M(+124.9%) | $183.30 M(+10.0%) |
| June 2004 | - | $23.30 M(-25.3%) | $166.60 M(+19.0%) |
| Mar 2004 | - | $31.20 M(-59.2%) | $140.00 M(+34.4%) |
| Dec 2003 | $104.20 M(+30.4%) | $76.40 M(+114.0%) | $104.20 M(+76.0%) |
| Sept 2003 | - | $35.70 M(-1181.8%) | $59.20 M(+29.5%) |
| June 2003 | - | -$3.30 M(-28.3%) | $45.70 M(-45.5%) |
| Mar 2003 | - | -$4.60 M(-114.6%) | $83.80 M(+4.9%) |
| Dec 2002 | $79.90 M(+26.8%) | $31.40 M(+41.4%) | $79.90 M(-6.1%) |
| Sept 2002 | - | $22.20 M(-36.2%) | $85.10 M(+5.8%) |
| June 2002 | - | $34.80 M(-509.4%) | $80.40 M(+12.9%) |
| Mar 2002 | - | -$8.50 M(-123.2%) | $71.20 M(+13.0%) |
| Dec 2001 | $63.00 M(-30.8%) | $36.60 M(+109.1%) | $63.00 M(-2.8%) |
| Sept 2001 | - | $17.50 M(-31.6%) | $64.80 M(-14.6%) |
| June 2001 | - | $25.60 M(-253.3%) | $75.90 M(+9.5%) |
| Mar 2001 | - | -$16.70 M(-143.5%) | $69.30 M(-23.8%) |
| Dec 2000 | $91.00 M(-32.1%) | $38.40 M(+34.3%) | $91.00 M(+73.0%) |
| Sept 2000 | - | $28.60 M(+50.5%) | $52.60 M(+119.2%) |
| June 2000 | - | $19.00 M(+280.0%) | $24.00 M(+380.0%) |
| Mar 2000 | - | $5.00 M | $5.00 M |
| Dec 1999 | $134.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual free cash flow?
- What is the all time high annual FCF for Edwards Lifesciences?
- What is Edwards Lifesciences annual FCF year-on-year change?
- What is Edwards Lifesciences quarterly free cash flow?
- What is the all time high quarterly FCF for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly FCF year-on-year change?
- What is Edwards Lifesciences TTM free cash flow?
- What is the all time high TTM FCF for Edwards Lifesciences?
- What is Edwards Lifesciences TTM FCF year-on-year change?
What is Edwards Lifesciences annual free cash flow?
The current annual FCF of EW is $629.50 M
What is the all time high annual FCF for Edwards Lifesciences?
Edwards Lifesciences all-time high annual free cash flow is $1.40 B
What is Edwards Lifesciences annual FCF year-on-year change?
Over the past year, EW annual free cash flow has changed by -$323.90 M (-33.97%)
What is Edwards Lifesciences quarterly free cash flow?
The current quarterly FCF of EW is $294.50 M
What is the all time high quarterly FCF for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly free cash flow is $762.00 M
What is Edwards Lifesciences quarterly FCF year-on-year change?
Over the past year, EW quarterly free cash flow has changed by -$61.70 M (-17.32%)
What is Edwards Lifesciences TTM free cash flow?
The current TTM FCF of EW is $490.10 M
What is the all time high TTM FCF for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM free cash flow is $1.43 B
What is Edwards Lifesciences TTM FCF year-on-year change?
Over the past year, EW TTM free cash flow has changed by -$284.80 M (-36.75%)